Sponsored Content
The ASSURE® Wearable Cardioverter Defibrillator (WCD) system from Kestra Medical Technologies provides important advantages based on patient-focused design and advanced technology.
WCDs work when patients wear them, with over 90% survival after an appropriate shock.1, 2, 3 Yet providers report challenges when it comes to patient compliance.
Now, there is a modern approach. Kestra designed the ASSURE system to enhance comfort, provide greater clarity to care teams, and increase patient confidence during their recovery after a cardiac event—because compliance matters.
Welcome to ASSURE.
1 Wäßnig, N.K., et al. Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death. Circulation. 2016;134(9):635-43.
2 Ellenbogen, K.A., et al. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry. JACC. 2017;3(3):243-250/.
3 Chung, M.K., et al. Aggregate National Experience With the Wearable Cardioverter-Defibrillator Vest: Event Rates, Compliance And Survival. Journal of the American College of Cardiology. 2010;56:194-203.
Click to watch the ASSURE Product Video
Click to read published study: Journal of Cardiovascular Electrophysiology “A Wearable Cardioverter Defibrillator With a Low False Alarm Rate”